Overview
Jarett Feldman is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Feldman has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Malabsorption, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Iron Deficiency Anemia.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1515 Holcombe Blvd, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MD Anderson
Matthew Campbell is a Hematologist and an Oncologist in Houston, Texas. Dr. Campbell is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.
MD Anderson
Amishi Shah is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Shah is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Bladder Cancer, and Nephrectomy.
MD Anderson
Eric Jonasch is an Oncologist in Houston, Texas. Dr. Jonasch is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Hemangioblastoma, Chromophobe Renal Cell Carcinoma, Hypothalamic Hamartomas, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AnemiaDr. Feldman isAdvanced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Feldman isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Iron Deficiency AnemiaDr. Feldman isAdvanced. Learn about Iron Deficiency Anemia.
- MalabsorptionDr. Feldman isAdvanced. Learn about Malabsorption.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Schnitzler SyndromeDr. Feldman isAdvanced. Learn about Schnitzler Syndrome.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Feldman isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Lymphoblastic Leukemia (ALL)Dr. Feldman isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Feldman isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Feldman isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Feldman isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Feldman isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.